Global Electronic Skin Patches Market: Focus on Type, Application, 14 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2024
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in this Report:
The Global Electronic Skin Patches industry analysis by BIS Research projects the market to grow at a significant CAGR of 17.22% during the forecast period, 2019-2024. The electronic skin patches market generated $3,899.1 million revenue in 2018.
The electronic skin patches growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of electronic skin patches, increasing burden of chronic and lifestyle associated diseases elevating the requirement of continuous monitoring and treatment of a disease, increasing inclination for personal health and fitness among adults, increasing healthcare expenditure, growing prominence for point-of-care technologies, and increasing penetration of mobile platforms, tablets, and smartphones. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in electronic skin patches. However, there are significant challenges which are restraining the market growth. These challenges include high initial cost and design complexity of electronic skin patches and lack of data security and lack of interoperability are limiting the adoption of electronic skin patches.
Expert Quote
“The diabetes management represents the biggest opportunity in the electronic skin patches market, as the demand of diabetes management skin patches and awareness about the diabetes are higher compared to other type of electronic skin patches. The upsurge prevalence of diabetes and growing geriatric population have made it the largest source of electronic skin patches for the treatment, monitoring, and diagnosis of diabetes.”
Scope of the Market Intelligence on Electronic Skin Patches Market
The electronic skin patches market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon detailed study of the products, associated with the market. In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global electronic skin patches market.
Market Segmentation
On the basis of type, the electronic skin patches market is segmented into therapeutic electronic skin patches and diagnostic and monitoring electronic skin patches.
On the basis of application, the electronic skin patches market is segmented into diabetes management, cardiovascular management and temperature monitoring, pain relief, and others.
Key Companies in the Electronic Skin Patches Industry
The key manufacturers that have been contributing significantly to the electronic skin patches market include Abbott Laboratories, BioTelemetry, Inc., DexCom, Inc., General Electric Company, Insulet Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals, Medtronic, Plc., MC10, Inc., Omron Corporation, VivaLNK, and VitalConnect among others.
Key Questions Answered in this Report:
- What are the different types of electronic skin patches available in the market, and what are the benefits offered by them?
- What are the major drivers, challenges, and opportunities in the global electronic skin patches market?
- What are the key development strategies implemented by the key players to stand out in this market?
- What are the regulations pertaining to the global electronic skin patches market?
- What are the initiatives implemented by different governmental bodies regulating the development and commercialization of electronic skin patches?
- What are the leading companies dominating the global electronic skin patches market?
- What are the perceptions of the investors about the global electronic skin patches market?
- How many types of electronic skin patches are available in the market, and which are the companies offering these?
- Based on the application, which electronic skin patches application is anticipated to witness a massive rise in demand in the forecast period 2019-2024?
- What was the market value in 2018 of the leading segments and sub-segments of the global electronic skin patches market?
- How is each segment of the global electronic skin patches market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2024?
- How is the industry anticipated to evolve during the forecast period 2019-2024?
- Which region is expected to contribute to the highest sales of the global electronic skin patches market during the forecast period?
- What are the leading trends and consumer preferences witnessed in global electronic skin patches markets?
The Global Electronic Skin Patches industry analysis by BIS Research projects the market to grow at a significant CAGR of 17.22% during the forecast period, 2019-2024. The electronic skin patches market generated $3,899.1 million revenue in 2018.
The electronic skin patches growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of electronic skin patches, increasing burden of chronic and lifestyle associated diseases elevating the requirement of continuous monitoring and treatment of a disease, increasing inclination for personal health and fitness among adults, increasing healthcare expenditure, growing prominence for point-of-care technologies, and increasing penetration of mobile platforms, tablets, and smartphones. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in electronic skin patches. However, there are significant challenges which are restraining the market growth. These challenges include high initial cost and design complexity of electronic skin patches and lack of data security and lack of interoperability are limiting the adoption of electronic skin patches.
Expert Quote
“The diabetes management represents the biggest opportunity in the electronic skin patches market, as the demand of diabetes management skin patches and awareness about the diabetes are higher compared to other type of electronic skin patches. The upsurge prevalence of diabetes and growing geriatric population have made it the largest source of electronic skin patches for the treatment, monitoring, and diagnosis of diabetes.”
Scope of the Market Intelligence on Electronic Skin Patches Market
The electronic skin patches market research provides a holistic view of the market in terms of various factors influencing it, regulatory reforms, and technological advancements. The scope of this report is centered upon detailed study of the products, associated with the market. In addition, the study also includes exhaustive information on the market needs, details on the new products, competitive landscape, market share of leading players, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to the global electronic skin patches market.
Market Segmentation
On the basis of type, the electronic skin patches market is segmented into therapeutic electronic skin patches and diagnostic and monitoring electronic skin patches.
On the basis of application, the electronic skin patches market is segmented into diabetes management, cardiovascular management and temperature monitoring, pain relief, and others.
Key Companies in the Electronic Skin Patches Industry
The key manufacturers that have been contributing significantly to the electronic skin patches market include Abbott Laboratories, BioTelemetry, Inc., DexCom, Inc., General Electric Company, Insulet Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals, Medtronic, Plc., MC10, Inc., Omron Corporation, VivaLNK, and VitalConnect among others.
Executive Summary
1 PRODUCT DEFINITION
2 SCOPE OF REPORT
2.1 Overview: Report Scope
2.2 Segmentation of the Global Electronic Skin Patches Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Method
3.4.1 Data and Prediction Modeling
3.4.2 Top-Down and Bottom-Up Approach
3.5 Validation of the Market Estimates and Projections
3.6 Industry Participants
3.7 Assumptions and Limitations
4 INDUSTRY ANALYSIS
4.1 Regulatory Scenario
4.1.1 Legal Requirements and Regulations
4.1.1.1 Regulations in the U.S.
4.1.1.2 Regulations in Europe
4.1.1.3 Regulations in Other Countries
4.2 Patent Analysis
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Strategies and Developments (2016-2019)
5.2.1 Joint Venture, Agreement, Collaborations, and Partnerships
5.2.2 Product Launches, Approvals, Licenses, and Clearances
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion
5.3 Market Share Analysis of Global Electronic Skin Patches Market (by Company), 2018
5.4 Growth Share Analysis
5.5 Product Mapping Analysis
6 GLOBAL ELECTRONIC SKIN PATCHES MARKET, 2018-2024
6.1 Assumptions and Limitations
6.2 Global Market Scenario
6.3 Market Dynamics
6.3.1 Overview
6.3.2 Impact Analysis
6.3.3 Market Drivers
6.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Electronic Skin Patches
6.3.3.2 Increasing Burden of Chronic and Lifestyle-Associated Diseases Elevating the Requirement of Continuous Monitoring and Treatment of a Disease
6.3.3.2.1 Increase in Prevalence of Diabetic Population
6.3.3.2.2 Increase in Prevalence of Cardiovascular Diseases
6.3.3.2.3 Surge in Number of Obese Individuals
6.3.3.3 Increasing Inclination for Personal Health and Fitness Amongst the Population
6.3.3.4 Increasing Healthcare Expenditure
6.3.3.5 Growing Prominence for Point-of-Care Technologies
6.3.3.6 Increasing Penetration of Mobile Platforms, Tablets, and Smartphones
6.3.4 Market Restraints
6.3.4.1 High Initial Cost and Design Complexity of Electronic Skin Patches Impeding the Growth in the Market
6.3.4.2 Lack of Data Security and Lack of Interoperability are Limiting the Adoption of Electronic Skin Patches
6.3.5 Market Opportunities
6.3.5.1 Untapped Market in Developing Economies
6.3.5.2 Scope for More Technologically Advanced Electronic Skin Patches
6.3.6 Market Trends
6.3.6.1 Increasing Adoption of Cloud Technology in Healthcare
7 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY TYPE
7.1 Overview
7.2 Monitoring and Diagnostic Electronic Skin Patches
7.3 Therapeutic Electronic Skin Patches
8 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY APPLICATION
8.1 Overview
8.2 Diabetes Management
8.3 Cardiovascular Management and Temperature Monitoring
8.4 Pain Management
8.5 Others
9 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY REGION
9.1 Overview
9.2 North America
9.2.1 North America Electronic Skin Patches Market (by Type)
9.2.2 North America Electronic Skin Patches Market (by Application)
9.2.3 North America Electronic Skin Patches Market (by Country)
9.2.3.1 U.S.
9.2.3.1.1 U.S. Electronic Skin Patches Market (by Type)
9.2.3.1.2 U.S. Electronic Skin Patches Market (by Application)
9.2.3.2 Canada
9.2.3.2.1 Canada Electronic Skin Patches Market (by Type)
9.2.3.2.2 Canada Electronic Skin Patches Market (by Application)
9.3 Europe
9.3.1 Europe Electronic Skin Patches Market (by Type)
9.3.2 Europe Electronic Skin Patches Market (by Application)
9.3.3 Europe Electronic Skin Patches Market (by Country)
9.3.3.1 Germany
9.3.3.1.1 Germany Electronic Skin Patches Market (by Type)
9.3.3.1.2 Germany Electronic Skin Patches Market (by Application)
9.3.3.2 U.K.
9.3.3.2.1 U.K. Electronic Skin Patches Market (by Type)
9.3.3.2.2 U.K. Electronic Skin Patches Market (by Application)
9.3.3.3 France
9.3.3.3.1 France Electronic Skin Patches Market (by Type)
9.3.3.3.2 France Electronic Skin Patches Market (by Application)
9.3.3.4 Italy
9.3.3.4.1 Italy Electronic Skin Patches Market (by Type)
9.3.3.4.2 Italy Electronic Skin Patches Market (by Application)
9.3.3.5 Spain
9.3.3.5.1 Spain Electronic Skin Patches Market (by Type)
9.3.3.5.2 Spain Electronic Skin Patches Market (by Application)
9.3.3.6 Rest-of-Europe
9.3.3.6.1 Rest-of-Europe Electronic Skin Patches Market (by Type)
9.3.3.6.2 Rest-of-Europe Electronic Skin Patches Market (by Application)
9.4 Asia-Pacific
9.4.1 Asia-Pacific Electronic Skin Patches Market (by Type)
9.4.2 Asia-Pacific Electronic Skin Patches Market (by Application)
9.4.3 Asia-Pacific Electronic Skin Patches Market (by Country)
9.4.3.1 Japan
9.4.3.1.1 Japan Electronic Skin Patches Market (by Type)
9.4.3.1.2 Japan Electronic Skin Patches Market (by Application)
9.4.3.2 China
9.4.3.2.1 China Electronic Skin Patches Market (by Type)
9.4.3.2.2 China Electronic Skin Patches Market (by Application)
9.4.3.3 India
9.4.3.3.1 India Electronic Skin Patches Market (by Type)
9.4.3.3.2 India Electronic Skin Patches Market (by Application)
9.4.3.4 South Korea
9.4.3.4.1 South Korea Electronic Skin Patches Market (by Type)
9.4.3.4.2 South Korea Electronic Skin Patches Market (by Application)
9.4.3.5 Australia
9.4.3.5.1 Australia Electronic Skin Patches Market (by Type)
9.4.3.5.2 Australia Electronic Skin Patches Market (by Application)
9.4.3.6 Rest-of-Asia-Pacific
9.4.3.6.1 Rest-of-Asia-Pacific Electronic Skin Patches Market (by Type)
9.4.3.6.2 Rest-of-Asia-Pacific Electronic Skin Patches Market (by Application)
9.5 Latin America
9.5.1 Latin America Electronic Skin Patches Market (by Type)
9.5.2 Latin America Electronic Skin Patches Market (by Application)
9.5.3 Latin America Electronic Skin Patches Market (by Country)
9.5.3.1 Brazil
9.5.3.1.1 Brazil Electronic Skin Patches Market (by Type)
9.5.3.1.2 Brazil Electronic Skin Patches Market (by Application)
9.5.3.2 Mexico
9.5.3.2.1 Mexico Electronic Skin Patches Market (by Type)
9.5.3.2.2 Mexico Electronic Skin Patches Market (by Application)
9.5.3.3 Rest-of-Latin America
9.5.3.3.1 Rest-of-Latin America Electronic Skin Patches Market (by Type)
9.5.3.3.2 Rest-of-Latin America Electronic Skin Patches Market (by Application)
9.6 Middle East and Africa
9.6.1 Middle East and Africa Electronic Skin Patches Market (by Type)
9.6.2 Middle East and Africa Electronic Skin Patches Market (by Application)
10 COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Role of Abbott Laboratories in the Electronic Skin Patches Market
10.1.3 Financials
10.1.4 SWOT Analysis
10.2 BioTelemetry, Inc.
10.2.1 Company Overview
10.2.2 Role of BioTelemetry, Inc. in the Electronic Skin Patches Market
10.2.3 Financials
10.2.4 SWOT Analysis
10.3 DexCom, Inc.
10.3.1 Company Overview
10.3.2 Role of DexCom, Inc. in the Electronic Skin Patches Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 General Electric Company
10.4.1 Company Overview
10.4.2 Role of General Electric Company in the Electronic Skin Patches Market
10.4.3 Financials
10.4.4 SWOT Analysis
10.5 Insulet Corporation
10.5.1 Company Overview
10.5.2 Role of Insulet Corporation in the Electronic Skin Patches Market
10.5.3 Financials
10.5.4 SWOT Analysis
10.6 iRhythm Technologies, Inc.
10.6.1 Company Overview
10.6.2 Role of iRhythm Technologies, Inc. in the Electronic Skin Patches Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 Koninklijke Philips N.V.
10.7.1 Company Overview
10.7.2 Role of Koninklijke Philips N.V. in the Global Electronic Skin Patches Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 LifeSignals
10.8.1 Company Overview
10.8.2 Role of LifeSignals in the Electronic Skin Patches Market
10.8.3 SWOT Analysis
10.9 Medtronic, Plc.
10.9.1 Company Overview
10.9.2 Role of Medtronic Plc in the Electronic Skin Patches Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.10 MC10, Inc.
10.10.1 Company Overview
10.10.2 Role of MC10, Inc. in the Electronic Skin Patches Market
10.10.3 SWOT Analysis
10.11 Nemaura Medical Inc.
10.11.1 Company Overview
10.11.2 Role of Nemaura Medical, Inc. in the Electronic Skin Patches Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Omron Corporation
10.12.1 Company Overview
10.12.2 Role of Omron Corporation in the Global Electronic Skin Patches Market
10.12.3 Financials
10.12.4 SWOT Analysis
10.13 Senseonics Holding, Inc.
10.13.1 Company Overview
10.13.2 Role of Senseonics Holdings, Inc. in the Electronic Skin Patches Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 VivaLNK
10.14.1 Company Overview
10.14.2 Role of VivaLNK in the Electronic Skin Patches Market
10.14.3 SWOT Analysis
10.15 VitalConnect
10.15.1 Company Overview
10.15.2 Role of VitalConnect in the Electronic Skin Patches Market
10.15.3 SWOT Analysis
1 PRODUCT DEFINITION
2 SCOPE OF REPORT
2.1 Overview: Report Scope
2.2 Segmentation of the Global Electronic Skin Patches Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered in the Report
2.5 Base Year and Forecast Period
3 RESEARCH METHODOLOGY
3.1 Overview: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Method
3.4.1 Data and Prediction Modeling
3.4.2 Top-Down and Bottom-Up Approach
3.5 Validation of the Market Estimates and Projections
3.6 Industry Participants
3.7 Assumptions and Limitations
4 INDUSTRY ANALYSIS
4.1 Regulatory Scenario
4.1.1 Legal Requirements and Regulations
4.1.1.1 Regulations in the U.S.
4.1.1.2 Regulations in Europe
4.1.1.3 Regulations in Other Countries
4.2 Patent Analysis
5 COMPETITIVE LANDSCAPE
5.1 Overview
5.2 Key Strategies and Developments (2016-2019)
5.2.1 Joint Venture, Agreement, Collaborations, and Partnerships
5.2.2 Product Launches, Approvals, Licenses, and Clearances
5.2.3 Mergers and Acquisitions
5.2.4 Business Expansion
5.3 Market Share Analysis of Global Electronic Skin Patches Market (by Company), 2018
5.4 Growth Share Analysis
5.5 Product Mapping Analysis
6 GLOBAL ELECTRONIC SKIN PATCHES MARKET, 2018-2024
6.1 Assumptions and Limitations
6.2 Global Market Scenario
6.3 Market Dynamics
6.3.1 Overview
6.3.2 Impact Analysis
6.3.3 Market Drivers
6.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Electronic Skin Patches
6.3.3.2 Increasing Burden of Chronic and Lifestyle-Associated Diseases Elevating the Requirement of Continuous Monitoring and Treatment of a Disease
6.3.3.2.1 Increase in Prevalence of Diabetic Population
6.3.3.2.2 Increase in Prevalence of Cardiovascular Diseases
6.3.3.2.3 Surge in Number of Obese Individuals
6.3.3.3 Increasing Inclination for Personal Health and Fitness Amongst the Population
6.3.3.4 Increasing Healthcare Expenditure
6.3.3.5 Growing Prominence for Point-of-Care Technologies
6.3.3.6 Increasing Penetration of Mobile Platforms, Tablets, and Smartphones
6.3.4 Market Restraints
6.3.4.1 High Initial Cost and Design Complexity of Electronic Skin Patches Impeding the Growth in the Market
6.3.4.2 Lack of Data Security and Lack of Interoperability are Limiting the Adoption of Electronic Skin Patches
6.3.5 Market Opportunities
6.3.5.1 Untapped Market in Developing Economies
6.3.5.2 Scope for More Technologically Advanced Electronic Skin Patches
6.3.6 Market Trends
6.3.6.1 Increasing Adoption of Cloud Technology in Healthcare
7 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY TYPE
7.1 Overview
7.2 Monitoring and Diagnostic Electronic Skin Patches
7.3 Therapeutic Electronic Skin Patches
8 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY APPLICATION
8.1 Overview
8.2 Diabetes Management
8.3 Cardiovascular Management and Temperature Monitoring
8.4 Pain Management
8.5 Others
9 GLOBAL ELECTRONIC SKIN PATCHES MARKET, BY REGION
9.1 Overview
9.2 North America
9.2.1 North America Electronic Skin Patches Market (by Type)
9.2.2 North America Electronic Skin Patches Market (by Application)
9.2.3 North America Electronic Skin Patches Market (by Country)
9.2.3.1 U.S.
9.2.3.1.1 U.S. Electronic Skin Patches Market (by Type)
9.2.3.1.2 U.S. Electronic Skin Patches Market (by Application)
9.2.3.2 Canada
9.2.3.2.1 Canada Electronic Skin Patches Market (by Type)
9.2.3.2.2 Canada Electronic Skin Patches Market (by Application)
9.3 Europe
9.3.1 Europe Electronic Skin Patches Market (by Type)
9.3.2 Europe Electronic Skin Patches Market (by Application)
9.3.3 Europe Electronic Skin Patches Market (by Country)
9.3.3.1 Germany
9.3.3.1.1 Germany Electronic Skin Patches Market (by Type)
9.3.3.1.2 Germany Electronic Skin Patches Market (by Application)
9.3.3.2 U.K.
9.3.3.2.1 U.K. Electronic Skin Patches Market (by Type)
9.3.3.2.2 U.K. Electronic Skin Patches Market (by Application)
9.3.3.3 France
9.3.3.3.1 France Electronic Skin Patches Market (by Type)
9.3.3.3.2 France Electronic Skin Patches Market (by Application)
9.3.3.4 Italy
9.3.3.4.1 Italy Electronic Skin Patches Market (by Type)
9.3.3.4.2 Italy Electronic Skin Patches Market (by Application)
9.3.3.5 Spain
9.3.3.5.1 Spain Electronic Skin Patches Market (by Type)
9.3.3.5.2 Spain Electronic Skin Patches Market (by Application)
9.3.3.6 Rest-of-Europe
9.3.3.6.1 Rest-of-Europe Electronic Skin Patches Market (by Type)
9.3.3.6.2 Rest-of-Europe Electronic Skin Patches Market (by Application)
9.4 Asia-Pacific
9.4.1 Asia-Pacific Electronic Skin Patches Market (by Type)
9.4.2 Asia-Pacific Electronic Skin Patches Market (by Application)
9.4.3 Asia-Pacific Electronic Skin Patches Market (by Country)
9.4.3.1 Japan
9.4.3.1.1 Japan Electronic Skin Patches Market (by Type)
9.4.3.1.2 Japan Electronic Skin Patches Market (by Application)
9.4.3.2 China
9.4.3.2.1 China Electronic Skin Patches Market (by Type)
9.4.3.2.2 China Electronic Skin Patches Market (by Application)
9.4.3.3 India
9.4.3.3.1 India Electronic Skin Patches Market (by Type)
9.4.3.3.2 India Electronic Skin Patches Market (by Application)
9.4.3.4 South Korea
9.4.3.4.1 South Korea Electronic Skin Patches Market (by Type)
9.4.3.4.2 South Korea Electronic Skin Patches Market (by Application)
9.4.3.5 Australia
9.4.3.5.1 Australia Electronic Skin Patches Market (by Type)
9.4.3.5.2 Australia Electronic Skin Patches Market (by Application)
9.4.3.6 Rest-of-Asia-Pacific
9.4.3.6.1 Rest-of-Asia-Pacific Electronic Skin Patches Market (by Type)
9.4.3.6.2 Rest-of-Asia-Pacific Electronic Skin Patches Market (by Application)
9.5 Latin America
9.5.1 Latin America Electronic Skin Patches Market (by Type)
9.5.2 Latin America Electronic Skin Patches Market (by Application)
9.5.3 Latin America Electronic Skin Patches Market (by Country)
9.5.3.1 Brazil
9.5.3.1.1 Brazil Electronic Skin Patches Market (by Type)
9.5.3.1.2 Brazil Electronic Skin Patches Market (by Application)
9.5.3.2 Mexico
9.5.3.2.1 Mexico Electronic Skin Patches Market (by Type)
9.5.3.2.2 Mexico Electronic Skin Patches Market (by Application)
9.5.3.3 Rest-of-Latin America
9.5.3.3.1 Rest-of-Latin America Electronic Skin Patches Market (by Type)
9.5.3.3.2 Rest-of-Latin America Electronic Skin Patches Market (by Application)
9.6 Middle East and Africa
9.6.1 Middle East and Africa Electronic Skin Patches Market (by Type)
9.6.2 Middle East and Africa Electronic Skin Patches Market (by Application)
10 COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Role of Abbott Laboratories in the Electronic Skin Patches Market
10.1.3 Financials
10.1.4 SWOT Analysis
10.2 BioTelemetry, Inc.
10.2.1 Company Overview
10.2.2 Role of BioTelemetry, Inc. in the Electronic Skin Patches Market
10.2.3 Financials
10.2.4 SWOT Analysis
10.3 DexCom, Inc.
10.3.1 Company Overview
10.3.2 Role of DexCom, Inc. in the Electronic Skin Patches Market
10.3.3 Financials
10.3.4 SWOT Analysis
10.4 General Electric Company
10.4.1 Company Overview
10.4.2 Role of General Electric Company in the Electronic Skin Patches Market
10.4.3 Financials
10.4.4 SWOT Analysis
10.5 Insulet Corporation
10.5.1 Company Overview
10.5.2 Role of Insulet Corporation in the Electronic Skin Patches Market
10.5.3 Financials
10.5.4 SWOT Analysis
10.6 iRhythm Technologies, Inc.
10.6.1 Company Overview
10.6.2 Role of iRhythm Technologies, Inc. in the Electronic Skin Patches Market
10.6.3 Financials
10.6.4 SWOT Analysis
10.7 Koninklijke Philips N.V.
10.7.1 Company Overview
10.7.2 Role of Koninklijke Philips N.V. in the Global Electronic Skin Patches Market
10.7.3 Financials
10.7.4 SWOT Analysis
10.8 LifeSignals
10.8.1 Company Overview
10.8.2 Role of LifeSignals in the Electronic Skin Patches Market
10.8.3 SWOT Analysis
10.9 Medtronic, Plc.
10.9.1 Company Overview
10.9.2 Role of Medtronic Plc in the Electronic Skin Patches Market
10.9.3 Financials
10.9.4 SWOT Analysis
10.10 MC10, Inc.
10.10.1 Company Overview
10.10.2 Role of MC10, Inc. in the Electronic Skin Patches Market
10.10.3 SWOT Analysis
10.11 Nemaura Medical Inc.
10.11.1 Company Overview
10.11.2 Role of Nemaura Medical, Inc. in the Electronic Skin Patches Market
10.11.3 Financials
10.11.4 SWOT Analysis
10.12 Omron Corporation
10.12.1 Company Overview
10.12.2 Role of Omron Corporation in the Global Electronic Skin Patches Market
10.12.3 Financials
10.12.4 SWOT Analysis
10.13 Senseonics Holding, Inc.
10.13.1 Company Overview
10.13.2 Role of Senseonics Holdings, Inc. in the Electronic Skin Patches Market
10.13.3 Financials
10.13.4 SWOT Analysis
10.14 VivaLNK
10.14.1 Company Overview
10.14.2 Role of VivaLNK in the Electronic Skin Patches Market
10.14.3 SWOT Analysis
10.15 VitalConnect
10.15.1 Company Overview
10.15.2 Role of VitalConnect in the Electronic Skin Patches Market
10.15.3 SWOT Analysis
LIST OF TABLES
Table 4.1: Regulatory Authority/ Association/ Consortium of the Global Electronic Skin Patches Market
Table 6.1: Percentage of Prevalence of Obesity among Adults in Different Countries, 2010, 2013, and 2016
Table 9.1: Prevalence of Diseases in North America, 2014-2017
Table 9.2: Prevalence of Diseases in the U.S., 2014-2017
Table 9.3: Statistics of Diabetes in Canada
Table 9.4: Prevalence of Diseases in Canada, 2014-2017
Table 9.5: Prevalence of Diseases in Europe, 2014-2017
Table 9.6: Prevalence of Diseases in Germany, 2014-2017
Table 9.7: Prevalence of Diseases in U.K., 2014-2017
Table 9.8: Prevalence of Diseases in France, 2014-2017
Table 9.9: Prevalence of Diseases in Italy, 2014-2017
Table 9.10: Prevalence of Diseases in Spain, 2014-2017
Table 9.11: Prevalence of Diseases in Asia, 2014-2017
Table 9.12: Prevalence of Diseases in Japan, 2014-2017
Table 9.13: Prevalence of Diseases in China, 2014-2017
Table 9.14: Prevalence of Diseases in India, 2014-2017
Table 9.15: Prevalence of Diseases in South Korea, 2014-2017
Table 9.16: Prevalence of Diseases in Australia, 2014-2017
Table 9.17: Prevalence of Diseases in Latin America and the Caribbean, 2014-2017
Table 9.18: Prevalence of Diseases in Brazil, 2014-2017
Table 9.19: Prevalence of Diseases in Mexico, 2014-2017
Table 9.20: Prevalence of Diseases in Argentina, 2014-2017
Table 9.21: Prevalence of Diseases in Middle East and North Africa, 2014-2017
Table 4.1: Regulatory Authority/ Association/ Consortium of the Global Electronic Skin Patches Market
Table 6.1: Percentage of Prevalence of Obesity among Adults in Different Countries, 2010, 2013, and 2016
Table 9.1: Prevalence of Diseases in North America, 2014-2017
Table 9.2: Prevalence of Diseases in the U.S., 2014-2017
Table 9.3: Statistics of Diabetes in Canada
Table 9.4: Prevalence of Diseases in Canada, 2014-2017
Table 9.5: Prevalence of Diseases in Europe, 2014-2017
Table 9.6: Prevalence of Diseases in Germany, 2014-2017
Table 9.7: Prevalence of Diseases in U.K., 2014-2017
Table 9.8: Prevalence of Diseases in France, 2014-2017
Table 9.9: Prevalence of Diseases in Italy, 2014-2017
Table 9.10: Prevalence of Diseases in Spain, 2014-2017
Table 9.11: Prevalence of Diseases in Asia, 2014-2017
Table 9.12: Prevalence of Diseases in Japan, 2014-2017
Table 9.13: Prevalence of Diseases in China, 2014-2017
Table 9.14: Prevalence of Diseases in India, 2014-2017
Table 9.15: Prevalence of Diseases in South Korea, 2014-2017
Table 9.16: Prevalence of Diseases in Australia, 2014-2017
Table 9.17: Prevalence of Diseases in Latin America and the Caribbean, 2014-2017
Table 9.18: Prevalence of Diseases in Brazil, 2014-2017
Table 9.19: Prevalence of Diseases in Mexico, 2014-2017
Table 9.20: Prevalence of Diseases in Argentina, 2014-2017
Table 9.21: Prevalence of Diseases in Middle East and North Africa, 2014-2017
LIST OF FIGURES
Figure 1: Global Electronic Skin Patches Market Snapshot
Figure 2: Global Electronic Skin Patches Market, 2018-2024
Figure 3: Market Drivers and Market Restraints
Figure 4: Competitive Scenario of Global Electronic Skin Patches Market, 2018
Figure 5: Strategic Developments in the Global Electronic Skin Patches Market, January 2016-October 2019
Figure 6: Global Electronic Skin Patches Market (by Type), 2018 and 2024
Figure 7: Growth Share Matrix of Global Electronic Skin Patches (by Application), 2018
Figure 8: Competitive Benchmarking by Application
Figure 9: Global Electronic Skin Patches Market Scenario, 2018 to 2024
Figure 1.1: Types of Skin Patches
Figure 1.2: Benefits of Electronic Skin Patches
Figure 2.1: Global Electronic Skin Patches: Market Segmentation
Figure 3.1: Electronic Skin Patches Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Considered Factors for Data Prediction and Modeling
Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
Figure 3.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.7: Data Triangulation
Figure 3.8: Total Number of Companies Profiles
Figure 3.9: Assumptions and Limitations
Figure 4.1: Share of Patent by Ownership, January 2016-October 2019
Figure 5.1: Competitive Landscape
Figure 5.2: Share of Key Developments and Strategies- January 2016-October 2019
Figure 5.3: Agreements, Collaborations, Joint Ventures, and Partnership (by Company), January 2016-October 2019
Figure 5.4: Product Launches, Approvals, Licenses, and Clearances (by Company), January 2016-October 2019
Figure 5.5: Mergers and Acquisitions (by Company), January 2016–October 2019
Figure 5.6: Business Expansion (by Company), January 2016-October 2019
Figure 5.7: Market Share Analysis of Global Electronic Skin Patches (by Company), 2018
Figure 5.8: Growth Share Matrix for Global Electronic Skin Patches Market (by Application), 2018
Figure 5.9: Competitive Benchmarking by Application
Figure 6.1: Segmentation of Electronic Skin Patches
Figure 6.2: Global Electronic Skin Patches Market, 2018-2024
Figure 6.3: Drivers, Restraints, and Opportunities of the Global Electronic Skin Patches Market
Figure 6.4: Impact Analysis
Figure 6.5: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.6: Number of People with Diabetes in 2017 and 2045 (20-79 years)
Figure 6.7: Percentage of Young Adults with Diabetes Developing Complications from the Disease
Figure 6.8: Statistics of Self-Tracking Health Data in the U.S.
Figure 6.9: Percentage of Young Adults Using Smartphones and Older Population Grabbing Smartphones in Different Countries
Figure 6.10: Benefits of Cloud Computing in Healthcare
Figure 7.1: Segmentation of Electronic Skin Patches Market (by Type)
Figure 7.2: Global Electronic Skin Patches Market (by Type), Market Share in 2018
Figure 7.3: Global Monitoring and Diagnostic Electronic Skin Patches Market, 2018-2024
Figure 7.4: Global Therapeutic Electronic Skin Patches Market, 2018-2024
Figure 8.1: Segmentation of Electronic Skin Patches Market (by Application)
Figure 8.2: Global Electronic Skin Patches Market (by Application), 2018 and 2024
Figure 8.3: Global Diabetes Management Market by Electronic Skin Patches, 2018-2024
Figure 8.4: Global Cardiovascular Management and Temperature Monitoring Market by Electronic Skin Patches, 2018-2024
Figure 8.5: Global Pain Management Market by Electronic Skin Patches, 2018-2024
Figure 8.6: Global Other Electronic Skin Patches Market, 2018-2024
Figure 9.1: Global Electronic Skin Patches Market Scenario, 2018 to 2024
Figure 9.2: North America Electronic Skin Patches Market, 2018-2024
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.5: North America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.6: North America Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.7: U.S. Electronic Skin Patches Market, 2018-2024
Figure 9.8: U.S. Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.9: U.S. Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.10: Canada Electronic Skin Patches Market, 2018-2024
Figure 9.11: Canada Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.12: Canada Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.13: Europe Electronic Skin Patches Market, 2018-2024
Figure 9.14: Europe: Market Dynamics
Figure 9.15: Europe Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.16: Europe Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.17: Europe Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.18: Germany Electronic Skin Patches Market, 2018-2024
Figure 9.19: Germany Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.20: Germany Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.21: U.K. Electronic Skin Patches Market, 2018-2024
Figure 9.22: U.K. Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.23: U.K. Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.24: Percentage of Total Deaths in France, in 2016
Figure 9.25: France Electronic Skin Patches Market, 2018-2024
Figure 9.26: France Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.27: France Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.28: Italy Electronic Skin Patches Market, 2018-2024
Figure 9.29: Italy Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.30: Italy Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.31: Spain Electronic Skin Patches Market, 2018-2024
Figure 9.32: Spain Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.33: Spain Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.34: Rest-of-Europe Electronic Skin Patches Market, 2018-2024
Figure 9.35: Rest-of-Europe Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.36: Rest-of-Europe Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.37: Asia-Pacific Electronic Skin Patches Market, 2018-2024
Figure 9.38: Asia-Pacific: Market Dynamics
Figure 9.39: Asia-Pacific Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.40: Asia-Pacific Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.41: Asia-Pacific Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.42: Japan Electronic Skin Patches Market, 2018-2024
Figure 9.43: Japan Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.44: Japan Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.45: China Electronic Skin Patches Market, 2018-2024
Figure 9.46: China Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.47: China Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.48: India Electronic Skin Patches Market, 2018-2024
Figure 9.49: India Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.50: India Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.51: South Korea Electronic Skin Patches Market, 2018-2024
Figure 9.52: South Korea Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.53: South Korea Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.54: Australia Electronic Skin Patches Market, 2018-2024
Figure 9.55: Australia Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.56: Australia Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.57: Rest-of-Asia-Pacific Electronic Skin Patches Market, 2018-2024
Figure 9.58: Rest-of-Asia-Pacific Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.59: Rest-of-Asia-Pacific Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.60: Latin America Electronic Skin Patches Market, 2018-2024
Figure 9.61: Latin America: Market Dynamics
Figure 9.62: Latin America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.63: Latin America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.64: Latin America Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.65: Brazil Electronic Skin Patches Market, 2018-2024
Figure 9.66: Brazil Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.67: Brazil Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.68: Mexico Electronic Skin Patches Market, 2018-2024
Figure 9.69: Mexico Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.70: Mexico Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.71: Rest-of-Latin America Electronic Skin Patches Market, 2018-2024
Figure 9.72: Rest-of-Latin America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.73: Rest-of-Latin America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.74: Middle East and Africa Electronic Skin Patches Market, 2018-2024
Figure 9.75: Middle East and Africa Market Dynamics
Figure 9.76: Middle East and Africa Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.77: Middle East and Africa Electronic Skin Patches Market (by Application), 2018-2024
Figure 10.1: Abbott Laboratories: Overall Product Portfolio
Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.3: Abbott Laboratories: Revenue (by Segment), 2016-2018
Figure 10.4: Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 10.5: Abbott Laboratories: Research and Development Expense, 2016-2018
Figure 10.6: Abbott Laboratories: SWOT Analysis
Figure 10.7: BioTelemetry, Inc.: Overall Product Portfolio
Figure 10.8: BioTelemetry, Inc.: Overall Financials, 2016-2018
Figure 10.9: BioTelemetry, Inc.: Revenue (by Segment), 2016-2018
Figure 10.10: BioTelemetry, Inc.: Research and Development Expense, 2016-2018
Figure 10.11: BioTelemetry, Inc.: SWOT Analysis
Figure 10.12: DexCom, Inc.: Overall Product Portfolio
Figure 10.13: DexCom, Inc.: Overall Financials, 2016-2018
Figure 10.14: DexCom, Inc.: Revenue (by Region), 2016-2018
Figure 10.15: DexCom, Inc.: Research and Development Expense, 2016-2018
Figure 10.16: DexCom, Inc.: SWOT Analysis
Figure 10.17: General Electric Company: Overall Product Portfolio
Figure 10.18: General Electric Company: Overall Financials, 2016-2018
Figure 10.19: General Electric Company: Revenue (by Segment), 2016-2018
Figure 10.20: General Electric Company: Revenue (by Region), 2016-2018
Figure 10.21: General Electric Company: Research and Development Expense, 2016-2018
Figure 10.22: General Electric Company: SWOT Analysis
Figure 10.23: Insulet Corporation: Overall Product Portfolio
Figure 10.24: Insulet Corporation: Overall Financials, 2016-2018
Figure 10.25: Insulet Corporation: Research and Development Expense, 2016-2018
Figure 10.26: Insulet Corporation: SWOT Analysis
Figure 10.27: iRhythm Technologies, Inc.: Overall Product Portfolio
Figure 10.28: iRhythm Technologies, Inc.: Overall Financials, 2016-2018
Figure 10.29: iRhythm Technologies, Inc.: Research and Development Expense, 2016-2018
Figure 10.30: iRhythm Technologies, Inc.: SWOT Analysis
Figure 10.31: Koninklijke Philips N.V.: Product Portfolio for Global Electronic Skin Patches Market
Figure 10.32: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 10.33: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
Figure 10.34: Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
Figure 10.35: Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
Figure 10.36: Koninklijke Philips N.V.: SWOT Analysis
Figure 10.37: LifeSignals: Overall Product Portfolio
Figure 10.38: LifeSignals: SWOT Analysis
Figure 10.39: Medtronic Plc: Product Portfolio for Electronic Skin Patches Market
Figure 10.40: Medtronic Plc: Overall Financials, 2017-2019
Figure 10.41: Medtronic Plc: Revenue (by Segment), 2017-2019
Figure 10.42: Medtronic Plc: Revenue (by Region), 2017-2019
Figure 10.43: Medtronic Plc: Research and Development Expense, 2017-2019
Figure 10.44: Medtronic Plc: SWOT Analysis
Figure 10.45: MC10, Inc.: Overall Product Portfolio
Figure 10.46: MC10, Inc.: SWOT Analysis
Figure 10.47: Nemaura Medical, Inc.: Overall Product Portfolio
Figure 10.48: Nemaura Medical, Inc.: Overall Financials, 2017-2019
Figure 10.49: Nemaura Medical, Inc.- Research and Development Expense, 2017-2019
Figure 10.50: Nemaura Medical, Inc.: SWOT Analysis
Figure 10.51: Omron Corporation: Product Portfolio for Global Electronic Skin Patches Market
Figure 10.52: Omron Corporation: Overall Financials, 2016-2018
Figure 10.53: Omron Corporation: Revenue by Segment, 2016-2018
Figure 10.54: Omron Corporation: Revenue by Region, 2016-2018
Figure 10.55: Omron Corporation: R&D Expenditure, 2016-2018
Figure 10.56: Omron Corporation: SWOT Analysis
Figure 10.57: Senseonics Holdings, Inc.: Overall Product Portfolio
Figure 10.58: Senseonics Holdings, Inc.: Overall Financials, 2016-2018
Figure 10.59: Senseonics Holdings, Inc.: Research and Development Expense, 2016-2018
Figure 10.60: Senseonics Holdings, Inc.: SWOT Analysis
Figure 10.61: VivaLNK: Overall Product Portfolio
Figure 10.62: VivaLNK: SWOT Analysis
Figure 10.63: VitalConnect: Overall Product Portfolio
Figure 10.64: VitalConnect: SWOT Analysis
Figure 1: Global Electronic Skin Patches Market Snapshot
Figure 2: Global Electronic Skin Patches Market, 2018-2024
Figure 3: Market Drivers and Market Restraints
Figure 4: Competitive Scenario of Global Electronic Skin Patches Market, 2018
Figure 5: Strategic Developments in the Global Electronic Skin Patches Market, January 2016-October 2019
Figure 6: Global Electronic Skin Patches Market (by Type), 2018 and 2024
Figure 7: Growth Share Matrix of Global Electronic Skin Patches (by Application), 2018
Figure 8: Competitive Benchmarking by Application
Figure 9: Global Electronic Skin Patches Market Scenario, 2018 to 2024
Figure 1.1: Types of Skin Patches
Figure 1.2: Benefits of Electronic Skin Patches
Figure 2.1: Global Electronic Skin Patches: Market Segmentation
Figure 3.1: Electronic Skin Patches Market Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Considered Factors for Data Prediction and Modeling
Figure 3.5: Top-Down Approach (Segment-Wise Analysis)
Figure 3.6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.7: Data Triangulation
Figure 3.8: Total Number of Companies Profiles
Figure 3.9: Assumptions and Limitations
Figure 4.1: Share of Patent by Ownership, January 2016-October 2019
Figure 5.1: Competitive Landscape
Figure 5.2: Share of Key Developments and Strategies- January 2016-October 2019
Figure 5.3: Agreements, Collaborations, Joint Ventures, and Partnership (by Company), January 2016-October 2019
Figure 5.4: Product Launches, Approvals, Licenses, and Clearances (by Company), January 2016-October 2019
Figure 5.5: Mergers and Acquisitions (by Company), January 2016–October 2019
Figure 5.6: Business Expansion (by Company), January 2016-October 2019
Figure 5.7: Market Share Analysis of Global Electronic Skin Patches (by Company), 2018
Figure 5.8: Growth Share Matrix for Global Electronic Skin Patches Market (by Application), 2018
Figure 5.9: Competitive Benchmarking by Application
Figure 6.1: Segmentation of Electronic Skin Patches
Figure 6.2: Global Electronic Skin Patches Market, 2018-2024
Figure 6.3: Drivers, Restraints, and Opportunities of the Global Electronic Skin Patches Market
Figure 6.4: Impact Analysis
Figure 6.5: Geriatric Population (60 years and above) Worldwide in Different Regions, 2000, 2015, 2030, and 2050
Figure 6.6: Number of People with Diabetes in 2017 and 2045 (20-79 years)
Figure 6.7: Percentage of Young Adults with Diabetes Developing Complications from the Disease
Figure 6.8: Statistics of Self-Tracking Health Data in the U.S.
Figure 6.9: Percentage of Young Adults Using Smartphones and Older Population Grabbing Smartphones in Different Countries
Figure 6.10: Benefits of Cloud Computing in Healthcare
Figure 7.1: Segmentation of Electronic Skin Patches Market (by Type)
Figure 7.2: Global Electronic Skin Patches Market (by Type), Market Share in 2018
Figure 7.3: Global Monitoring and Diagnostic Electronic Skin Patches Market, 2018-2024
Figure 7.4: Global Therapeutic Electronic Skin Patches Market, 2018-2024
Figure 8.1: Segmentation of Electronic Skin Patches Market (by Application)
Figure 8.2: Global Electronic Skin Patches Market (by Application), 2018 and 2024
Figure 8.3: Global Diabetes Management Market by Electronic Skin Patches, 2018-2024
Figure 8.4: Global Cardiovascular Management and Temperature Monitoring Market by Electronic Skin Patches, 2018-2024
Figure 8.5: Global Pain Management Market by Electronic Skin Patches, 2018-2024
Figure 8.6: Global Other Electronic Skin Patches Market, 2018-2024
Figure 9.1: Global Electronic Skin Patches Market Scenario, 2018 to 2024
Figure 9.2: North America Electronic Skin Patches Market, 2018-2024
Figure 9.3: North America: Market Dynamics
Figure 9.4: North America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.5: North America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.6: North America Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.7: U.S. Electronic Skin Patches Market, 2018-2024
Figure 9.8: U.S. Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.9: U.S. Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.10: Canada Electronic Skin Patches Market, 2018-2024
Figure 9.11: Canada Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.12: Canada Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.13: Europe Electronic Skin Patches Market, 2018-2024
Figure 9.14: Europe: Market Dynamics
Figure 9.15: Europe Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.16: Europe Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.17: Europe Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.18: Germany Electronic Skin Patches Market, 2018-2024
Figure 9.19: Germany Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.20: Germany Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.21: U.K. Electronic Skin Patches Market, 2018-2024
Figure 9.22: U.K. Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.23: U.K. Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.24: Percentage of Total Deaths in France, in 2016
Figure 9.25: France Electronic Skin Patches Market, 2018-2024
Figure 9.26: France Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.27: France Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.28: Italy Electronic Skin Patches Market, 2018-2024
Figure 9.29: Italy Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.30: Italy Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.31: Spain Electronic Skin Patches Market, 2018-2024
Figure 9.32: Spain Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.33: Spain Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.34: Rest-of-Europe Electronic Skin Patches Market, 2018-2024
Figure 9.35: Rest-of-Europe Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.36: Rest-of-Europe Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.37: Asia-Pacific Electronic Skin Patches Market, 2018-2024
Figure 9.38: Asia-Pacific: Market Dynamics
Figure 9.39: Asia-Pacific Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.40: Asia-Pacific Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.41: Asia-Pacific Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.42: Japan Electronic Skin Patches Market, 2018-2024
Figure 9.43: Japan Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.44: Japan Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.45: China Electronic Skin Patches Market, 2018-2024
Figure 9.46: China Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.47: China Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.48: India Electronic Skin Patches Market, 2018-2024
Figure 9.49: India Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.50: India Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.51: South Korea Electronic Skin Patches Market, 2018-2024
Figure 9.52: South Korea Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.53: South Korea Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.54: Australia Electronic Skin Patches Market, 2018-2024
Figure 9.55: Australia Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.56: Australia Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.57: Rest-of-Asia-Pacific Electronic Skin Patches Market, 2018-2024
Figure 9.58: Rest-of-Asia-Pacific Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.59: Rest-of-Asia-Pacific Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.60: Latin America Electronic Skin Patches Market, 2018-2024
Figure 9.61: Latin America: Market Dynamics
Figure 9.62: Latin America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.63: Latin America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.64: Latin America Electronic Skin Patches Market (by Country), 2018 and 2024
Figure 9.65: Brazil Electronic Skin Patches Market, 2018-2024
Figure 9.66: Brazil Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.67: Brazil Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.68: Mexico Electronic Skin Patches Market, 2018-2024
Figure 9.69: Mexico Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.70: Mexico Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.71: Rest-of-Latin America Electronic Skin Patches Market, 2018-2024
Figure 9.72: Rest-of-Latin America Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.73: Rest-of-Latin America Electronic Skin Patches Market (by Application), 2018-2024
Figure 9.74: Middle East and Africa Electronic Skin Patches Market, 2018-2024
Figure 9.75: Middle East and Africa Market Dynamics
Figure 9.76: Middle East and Africa Electronic Skin Patches Market (by Type), 2018-2024
Figure 9.77: Middle East and Africa Electronic Skin Patches Market (by Application), 2018-2024
Figure 10.1: Abbott Laboratories: Overall Product Portfolio
Figure 10.2: Abbott Laboratories: Overall Financials, 2016-2018
Figure 10.3: Abbott Laboratories: Revenue (by Segment), 2016-2018
Figure 10.4: Abbott Laboratories: Revenue (by Region), 2016-2018
Figure 10.5: Abbott Laboratories: Research and Development Expense, 2016-2018
Figure 10.6: Abbott Laboratories: SWOT Analysis
Figure 10.7: BioTelemetry, Inc.: Overall Product Portfolio
Figure 10.8: BioTelemetry, Inc.: Overall Financials, 2016-2018
Figure 10.9: BioTelemetry, Inc.: Revenue (by Segment), 2016-2018
Figure 10.10: BioTelemetry, Inc.: Research and Development Expense, 2016-2018
Figure 10.11: BioTelemetry, Inc.: SWOT Analysis
Figure 10.12: DexCom, Inc.: Overall Product Portfolio
Figure 10.13: DexCom, Inc.: Overall Financials, 2016-2018
Figure 10.14: DexCom, Inc.: Revenue (by Region), 2016-2018
Figure 10.15: DexCom, Inc.: Research and Development Expense, 2016-2018
Figure 10.16: DexCom, Inc.: SWOT Analysis
Figure 10.17: General Electric Company: Overall Product Portfolio
Figure 10.18: General Electric Company: Overall Financials, 2016-2018
Figure 10.19: General Electric Company: Revenue (by Segment), 2016-2018
Figure 10.20: General Electric Company: Revenue (by Region), 2016-2018
Figure 10.21: General Electric Company: Research and Development Expense, 2016-2018
Figure 10.22: General Electric Company: SWOT Analysis
Figure 10.23: Insulet Corporation: Overall Product Portfolio
Figure 10.24: Insulet Corporation: Overall Financials, 2016-2018
Figure 10.25: Insulet Corporation: Research and Development Expense, 2016-2018
Figure 10.26: Insulet Corporation: SWOT Analysis
Figure 10.27: iRhythm Technologies, Inc.: Overall Product Portfolio
Figure 10.28: iRhythm Technologies, Inc.: Overall Financials, 2016-2018
Figure 10.29: iRhythm Technologies, Inc.: Research and Development Expense, 2016-2018
Figure 10.30: iRhythm Technologies, Inc.: SWOT Analysis
Figure 10.31: Koninklijke Philips N.V.: Product Portfolio for Global Electronic Skin Patches Market
Figure 10.32: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 10.33: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
Figure 10.34: Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
Figure 10.35: Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
Figure 10.36: Koninklijke Philips N.V.: SWOT Analysis
Figure 10.37: LifeSignals: Overall Product Portfolio
Figure 10.38: LifeSignals: SWOT Analysis
Figure 10.39: Medtronic Plc: Product Portfolio for Electronic Skin Patches Market
Figure 10.40: Medtronic Plc: Overall Financials, 2017-2019
Figure 10.41: Medtronic Plc: Revenue (by Segment), 2017-2019
Figure 10.42: Medtronic Plc: Revenue (by Region), 2017-2019
Figure 10.43: Medtronic Plc: Research and Development Expense, 2017-2019
Figure 10.44: Medtronic Plc: SWOT Analysis
Figure 10.45: MC10, Inc.: Overall Product Portfolio
Figure 10.46: MC10, Inc.: SWOT Analysis
Figure 10.47: Nemaura Medical, Inc.: Overall Product Portfolio
Figure 10.48: Nemaura Medical, Inc.: Overall Financials, 2017-2019
Figure 10.49: Nemaura Medical, Inc.- Research and Development Expense, 2017-2019
Figure 10.50: Nemaura Medical, Inc.: SWOT Analysis
Figure 10.51: Omron Corporation: Product Portfolio for Global Electronic Skin Patches Market
Figure 10.52: Omron Corporation: Overall Financials, 2016-2018
Figure 10.53: Omron Corporation: Revenue by Segment, 2016-2018
Figure 10.54: Omron Corporation: Revenue by Region, 2016-2018
Figure 10.55: Omron Corporation: R&D Expenditure, 2016-2018
Figure 10.56: Omron Corporation: SWOT Analysis
Figure 10.57: Senseonics Holdings, Inc.: Overall Product Portfolio
Figure 10.58: Senseonics Holdings, Inc.: Overall Financials, 2016-2018
Figure 10.59: Senseonics Holdings, Inc.: Research and Development Expense, 2016-2018
Figure 10.60: Senseonics Holdings, Inc.: SWOT Analysis
Figure 10.61: VivaLNK: Overall Product Portfolio
Figure 10.62: VivaLNK: SWOT Analysis
Figure 10.63: VitalConnect: Overall Product Portfolio
Figure 10.64: VitalConnect: SWOT Analysis
